You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

X4 Pharms Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for X4 PHARMS, and what generic alternatives to X4 PHARMS drugs are available?

X4 PHARMS has one approved drug.

There are six US patents protecting X4 PHARMS drugs.

There are forty-three patent family members on X4 PHARMS drugs in eighteen countries.

Summary for X4 Pharms
International Patents:43
US Patents:6
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for X4 Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
X4 Pharms XOLREMDI mavorixafor CAPSULE;ORAL 218709-001 Apr 26, 2024 RX Yes Yes ⤷  Subscribe ⤷  Subscribe
X4 Pharms XOLREMDI mavorixafor CAPSULE;ORAL 218709-001 Apr 26, 2024 RX Yes Yes ⤷  Subscribe ⤷  Subscribe
X4 Pharms XOLREMDI mavorixafor CAPSULE;ORAL 218709-001 Apr 26, 2024 RX Yes Yes 10,548,889 ⤷  Subscribe Y ⤷  Subscribe
X4 Pharms XOLREMDI mavorixafor CAPSULE;ORAL 218709-001 Apr 26, 2024 RX Yes Yes 12,115,156 ⤷  Subscribe Y ⤷  Subscribe
X4 Pharms XOLREMDI mavorixafor CAPSULE;ORAL 218709-001 Apr 26, 2024 RX Yes Yes 10,610,527 ⤷  Subscribe ⤷  Subscribe
X4 Pharms XOLREMDI mavorixafor CAPSULE;ORAL 218709-001 Apr 26, 2024 RX Yes Yes 11,045,461 ⤷  Subscribe Y ⤷  Subscribe
X4 Pharms XOLREMDI mavorixafor CAPSULE;ORAL 218709-001 Apr 26, 2024 RX Yes Yes 11,219,621 ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.